The colonic epithelium continuously regenerates with transitions through various cellular phases including proliferation, differentiation and cell death via apoptosis. Human colonic adenocarcinoma (Caco-2) cells in culture undergo spontaneous differentiation into mature enterocytes in association with progressive increases in expression of glutathione S-transferase alpha-1 (GSTA1). We hypothesize that GSTA1 plays a functional role in controlling proliferation, differentiation and apoptosis in Caco-2 cells. We demonstrate increased GSTA1 levels associated with decreased proliferation and increased expression of differentiation markers alkaline phosphatase, villin, dipeptidyl peptidase-4 and E-cadherin in postconfluent Caco-2 cells. Results of MTS assays, BrdU incorporation and flow cytometry indicate that forced expression of GSTA1 significantly reduces cellular proliferation and siRNA-mediated down-regulation of GSTA1 significantly increases cells in S-phase and associated cell proliferation. Sodium butyrate (NaB) at a concentration of 1 mM reduces Caco-2 cell proliferation, increases differentiation and increases GSTA1 activity 4-fold by 72 hours. In contrast, 10 mM NaB causes significant toxicity in preconfluent cells via apoptosis through caspase-3 activation with reduced GSTA1 activity. However, GSTA1 down-regulation by siRNA does not alter NaB-induced differentiation or apoptosis in Caco-2 cells. While 10 mM NaB causes GSTA1-JNK complex dissociation, phosphorylation of JNK is not altered. These findings suggest that GSTA1 levels may play a role in modulating enterocyte proliferation but do not influence differentiation or apoptosis.
References
[1]
Hayes JD, Flanagan JU, Jowsey IR (2005) Glutathione transferases. Annual review of pharmacology and toxicology 45: 51–88.
[2]
Uchida K (2000) Induction of glutathione S-transferase by prostaglandins. Mechanisms of ageing and development 116: 135–140.
[3]
Tetlow N, Coggan M, Casarotto MG, Board PG (2004) Functional polymorphism of human glutathione transferase A3: effects on xenobiotic metabolism and steroid biosynthesis. Pharmacogenetics 14: 657–663.
[4]
Agarwal R, Raza H, Allyn DL, Bickers DR, Mukhtar H (1992) Glutathione S-transferase-dependent conjugation of leukotriene A4-methyl ester to leukotriene C4-methyl ester in mammalian skin. Biochemical pharmacology 44: 2047–2053.
[5]
Balogh LM, Roberts AG, Shireman LM, Greene RJ, Atkins WM (2008) The stereochemical course of 4-hydroxy-2-nonenal metabolism by glutathione S-transferases. The Journal of biological chemistry 283: 16702–16710.
[6]
Paumi CM, Ledford BG, Smitherman PK, Townsend AJ, Morrow CS (2001) Role of multidrug resistance protein 1 (MRP1) and glutathione S-transferase A1-1 in alkylating agent resistance. Kinetics of glutathione conjugate formation and efflux govern differential cellular sensitivity to chlorambucil versus melphalan toxicity. The Journal of biological chemistry 276: 7952–7956.
[7]
Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, et al. (1999) Regulation of JNK signaling by GSTp. The EMBO journal 18: 1321–1334.
[8]
Holley SL, Fryer AA, Haycock JW, Grubb SE, Strange RC, et al. (2007) Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis. Carcinogenesis 28: 2268–2273.
[9]
Laborde E (2010) Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death. Cell death and differentiation 17: 1373–1380.
[10]
Chopra DP, Dombkowski AA, Stemmer PM, Parker GC (2010) Intestinal epithelial cells in vitro. Stem cells and development 19: 131–142.
[11]
Hilgers AR, Conradi RA, Burton PS (1990) Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharmaceutical research 7: 902–910.
[12]
Hidalgo IJ, Raub TJ, Borchardt RT (1989) Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96: 736–749.
[13]
Ferruzza S, Rossi C, Scarino ML, Sambuy Y (2011) A protocol for in situ enzyme assays to assess the differentiation of human intestinal Caco-2 cells. Toxicol In Vitro.
[14]
Romero L, Andrews K, Ng L, ORourke K, Maslen A, et al. (2006) Human GSTA1-1 reduces c-Jun N-terminal kinase signalling and apoptosis in Caco-2 cells. The Biochemical journal 400: 135–141.
[15]
Simon-Assmann P, Turck N, Sidhoum-Jenny M, Gradwohl G, Kedinger M (2007) In vitro models of intestinal epithelial cell differentiation. Cell biology and toxicology 23: 241–256.
[16]
Fulda S (2009) Tumor resistance to apoptosis. International journal of cancer Journal international du cancer 124: 511–515.
[17]
Menard D (2004) Functional development of the human gastrointestinal tract: hormone- and growth factor-mediated regulatory mechanisms. Can J Gastroenterol 18: 39–44.
[18]
Orchel A, Dzierzewicz Z, Parfiniewicz B, Weglarz L, Wilczok T (2005) Butyrate-induced differentiation of colon cancer cells is PKC and JNK dependent. Digestive diseases and sciences 50: 490–498.
[19]
Dzierzewicz Z, Orchel A, Weglarz L, Latocha M, Wilczok T (2002) Changes in the cellular behaviour of human colonic cell line Caco-2 in response to butyrate treatment. Acta biochimica Polonica 49: 211–220.
[20]
Mariadason JM, Velcich A, Wilson AJ, Augenlicht LH, Gibson PR (2001) Resistance to butyrate-induced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation. Gastroenterology 120: 889–899.
[21]
Pettersson PL, Mannervik B (2001) The role of glutathione in the isomerization of delta 5-androstene-3,17-dione catalyzed by human glutathione transferase A1-1. The Journal of biological chemistry 276: 11698–11704.
[22]
Bull AW, Steffensen KR, Leers J, Rafter JJ (2003) Activation of PPAR gamma in colon tumor cell lines by oxidized metabolites of linoleic acid, endogenous ligands for PPAR gamma. Carcinogenesis 24: 1717–1722.
[23]
Liu X, Yang JM, Zhang SS, Liu XY, Liu DX (2010) Induction of cell cycle arrest at G1 and S phases and cAMP-dependent differentiation in C6 glioma by low concentration of cycloheximide. BMC cancer 10: 684.
[24]
Liang FQ, Alssadi R, Morehead P, Awasthi YC, Godley BF (2005) Enhanced expression of glutathione-S-transferase A1-1 protects against oxidative stress in human retinal pigment epithelial cells. Experimental eye research 80: 113–119.
[25]
Sharma A, Patrick B, Li J, Sharma R, Jeyabal PV, et al. (2006) Glutathione S-transferases as antioxidant enzymes: small cell lung cancer (H69) cells transfected with hGSTA1 resist doxorubicin-induced apoptosis. Archives of biochemistry and biophysics 452: 165–173.
[26]
Ruscoe JE, Rosario LA, Wang T, Gate L, Arifoglu P, et al. (2001) Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. The Journal of pharmacology and experimental therapeutics 298: 339–345.
[27]
Hokaiwado N, Takeshita F, Naiki-Ito A, Asamoto M, Ochiya T, et al. (2008) Glutathione S-transferase Pi mediates proliferation of androgen-independent prostate cancer cells. Carcinogenesis 29: 1134–1138.
[28]
Chantret I, Rodolosse A, Barbat A, Dussaulx E, Brot-Laroche E, et al. (1994) Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation. Journal of cell science 107 ( Pt 1): 213–225.
[29]
Pshezhetsky AV, Fedjaev M, Ashmarina L, Mazur A, Budman L, et al. (2007) Subcellular proteomics of cell differentiation: quantitative analysis of the plasma membrane proteome of Caco-2 cells. Proteomics 7: 2201–2215.
[30]
Scharmach E, Hessel S, Niemann B, Lampen A (2009) Glutathione S-transferase expression and isoenzyme composition during cell differentiation of Caco-2 cells. Toxicology 265: 122–126.
[31]
Ng L, Nichols K, ORourke K, Maslen A, Kirby GM (2007) Repression of human GSTA1 by interleukin-1beta is mediated by variant hepatic nuclear factor-1C. Molecular pharmacology 71: 201–208.
[32]
Ebert MN, Klinder A, Peters WH, Schaferhenrich A, Sendt W, et al. (2003) Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate. Carcinogenesis 24: 1637–1644.
[33]
Louis M, Rosato RR, Brault L, Osbild S, Battaglia E, et al. (2004) The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stress. International journal of oncology 25: 1701–1711.
[34]
Matthews GM, Howarth GS, Butler RN (2012) Short-chain fatty acids induce apoptosis in colon cancer cells associated with changes to intracellular redox state and glucose metabolism. Chemotherapy 58: 102–109.
[35]
Townsend DM, Findlay VL, Tew KD (2005) Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets. Methods in enzymology 401: 287–307.
[36]
Castro-Caldas M, Milagre I, Rodrigues E, Gama MJ (2009) Glutathione S-transferase pi regulates UV-induced JNK signaling in SH-SY5Y neuroblastoma cells. Neuroscience letters 451: 241–245.
[37]
Turella P, Cerella C, Filomeni G, Bullo A, De Maria F, et al. (2005) Proapoptotic activity of new glutathione S-transferase inhibitors. Cancer research 65: 3751–3761.
[38]
Burg D, Riepsaame J, Pont C, Mulder G, van de Water B (2006) Peptide-bond modified glutathione conjugate analogs modulate GSTpi function in GSH-conjugation, drug sensitivity and JNK signaling. Biochemical pharmacology 71: 268–277.
[39]
Liu J, Lin A (2005) Role of JNK activation in apoptosis: a double-edged sword. Cell research 15: 36–42.
[40]
Mandal M, Olson DJ, Sharma T, Vadlamudi RK, Kumar R (2001) Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-Jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells. Gastroenterology 120: 71–78.
[41]
Stokrova J, Sloncova E, Sovova V, Kucerova D, Zila V, et al. (2006) Characterization of four clones derived from human adenocarcinoma cell line, HT29, and analysis of their response to sodium butyrate. Int J Oncol 28: 559–565.
[42]
Schwab M, Reynders V, Ulrich S, Zahn N, Stein J, et al. (2006) PPARgamma is a key target of butyrate-induced caspase-3 activation in the colorectal cancer cell line Caco-2. Apoptosis 11: 1801–1811.
